Adverse events to the nimotuzumab in patients with primary cerebral tumor

• Main Authors: Yasley Gámez Fernández (Author), Leonardo Ramos Hernández (Author), Soraida Cándida Acosta Brooks (Author), Sandra Peacok Aldana (Author)
• Formato: Livro
• Publicado em: Centro Provincial de Información de Ciencias Médicas, 2022-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction: The nimotuzumab is a monoclonal antibody used in the treatment of patients with cerebral tumor. The realization of pharmaco surveillance studies that guaranteed its security is justified given its new features.   Objective: To characterize the adverse events related to this medicine in...